Receiving a PBM audit notice from OptumRx, CVS Caremark, Express Scripts, Prime Therapeutics, Humana, or another pharmacy benefit manager and/or insurance payor is stressful. Yet many independent pharmacy owners unknowingly make critical mistakes in the days and weeks that follow, mistakes that transform a manageable audit into a network termination, substantial recoupment, or even a government investigation.
At Health Law Alliance, we have represented pharmacies nationwide in thousands of PBM matters. One lesson has become clear: the pharmacies that achieve the best outcomes are rarely those with perfect records. They are the ones that respond strategically from the very beginning.
Mistake #1: Treating the Audit as a Routine Administrative Matter
Many pharmacy owners assume an audit is simply a request for records. In reality, PBM audits have evolved into sophisticated enforcement tools. Every document submitted, every explanation provided, and every communication with the pharmacy becomes part of the record that may later determine whether the pharmacy remains in network.
By the time a network termination notice arrives, the PBM has often already formed its opinion based largely on the pharmacy's initial audit response. Waiting until termination to develop a legal strategy is frequently too late.
Mistake #2: Focusing Only on the Claims Instead of the Bigger Picture
One of the most common errors is responding claim-by-claim without addressing the broader narrative.
PBMs are increasingly looking beyond individual discrepancies. They evaluate whether findings suggest larger compliance concerns, operational weaknesses, or alleged patterns of conduct. A successful audit response must therefore do more than explain isolated claims, it should demonstrate that the pharmacy maintains robust compliance systems, appropriate oversight, and good-faith adherence to applicable laws, regulations, and provider manual requirements.
Mistake #3: Failing to Create a Strong Documentary Record
An audit response is not simply an opportunity to answer questions, it is often the pharmacy's only chance to build the record that will be reviewed during subsequent appeals, credentialing decisions, litigation, arbitration, or regulatory investigations.
Supporting documentation should be organized, complete, and accompanied by a clear explanation of why the PBM's conclusions are incorrect. Pharmacies that merely submit records without context frequently miss the opportunity to rebut assumptions before they become formal findings.
Mistake #4: Waiting Until Final Findings to Seek Counsel
Many pharmacies attempt to handle preliminary audit findings internally and only contact an attorney after receiving a final audit report, recoupment notices, or network termination notice.
By that stage, important strategic opportunities may already have been lost. Early legal involvement often allows counsel to identify weaknesses in the PBM's methodology, preserve favorable legal arguments, coordinate document production, and present the pharmacy's position before adverse findings become entrenched.
Mistake #5: Assuming Small Findings Will Stay Small
One incorrect NDC, one missing signature log, one inventory discrepancy, or one documentation issue may appear insignificant in isolation.
However, PBMs increasingly evaluate findings collectively rather than individually. Multiple minor discrepancies can be cited as evidence of broader compliance concerns and used to justify larger recoupments, expanded audits, credentialing actions, or network termination. The financial value of the finding is often far less important than how the PBM characterizes it.
Mistake #6: Ignoring the Collateral Consequences
Many pharmacy owners focus exclusively on the immediate audit findings while overlooking the broader risks.
PBM audit findings may later be reviewed by CMS, UPICs, state Medicaid agencies, Boards of Pharmacy, DEA investigators, commercial payors, licensing authorities, or law enforcement. An effective response should therefore address not only the PBM's concerns but also anticipate how the documentation may be interpreted by other regulators if additional scrutiny arises.
The Best PBM Audit Defense Begins Before a Termination Notice
The strongest audit defenses are proactive rather than reactive. Successful pharmacies maintain organized documentation, conduct internal compliance reviews, implement corrective actions when appropriate, and respond to audits with a comprehensive legal and factual strategy instead of treating them as routine paperwork exercises. A well-prepared response can often prevent a dispute from escalating into recoupments and/or network termination.
How Health Law Alliance Can Help
Health Law Alliance represents independent pharmacies nationwide in PBM audits, PBM network terminations, credentialing denials, payment suspensions, recoupment disputes, Special Investigations Unit (SIU) investigations, and related healthcare regulatory matters. Our attorneys routinely defend pharmacies against audits initiated by OptumRx, CVS Caremark, Express Scripts, Prime Therapeutics, Humana, MedImpact, Navitus, and other national PBMs.
If your pharmacy has received a PBM audit notice, preliminary or final audit findings, a credentialing denial, or a network termination notice, early legal intervention can make a substantial difference in the outcome. Contact Health Law Alliance today for a free consultation to discuss your options and develop a strategic defense.
